A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

26118.2 PFLS-LS

Project title

A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-

Inserted texts

Category	Text
Short description (German)	A novel Lineage Prediction and Enhancement technology (L-PET) to unlock the therapeutic and commercial potential of stem cell-based diabetes therapies
Short description (English)
Abstract (German)	Capitalizing on programmable cell fate regulation, we present a high-content screening platform measuring the differentiation capacity of pluripotent stem cells in a rapid, non-disruptive and inexpensive manner, enabling identification of high-quality stem cells for commercial applications.
Abstract (English)